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Incontinentia Pigmenti in a Newborn with NEMO Mutation 
Incontinentia pigmenti (IP) (OMIM #308300) is a rare X-linked dominant neuroectodermal 
multisystemic syndrome due to mutations in the gene for NF-κB essential modulator 
(NEMO). A term newborn girl who was born with erythematous vesicular eruptions 
developed recurrent seizures during the first and second weeks of her life. The serial MRIs 
demonstrated diffuse, progressive brain infarctions and subsequent encephalomalacia as 
well as brain atrophy. Skin biopsy found it was consistent with the vesicular stage of IP. 
Genetic analysis revealed a deletion exon 4-10 in NEMO gene associated with IP. We 
hereby report a Korean female baby with IP confirmed by mutation analysis of NEMO 
gene.
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CASE REPORT
Pediatrics
INTRODUCTION
Incontinentia pigmenti (IP) is a rare X-linked dominant inherit-
ed disorder due to a mutation in the NF-κB essential modulator 
(NEMO)/inhibitor kappa kinase (IKK)-gamma gene. It primar-
ily affects the tissues and organs derived from ectoderm or neu-
roectoderm and represents a type of ectodermal dysplasia. The 
skin lesions, linear blisters in an otherwise well baby girl, are the 
most characteristic feature of IP, although the inflammatory stage 
may be absent or occur in utero. The skin lesions usually pres-
ent in four stages: 1) vesicobullous lesions on the limbs and 
scalp, and frequently on the trunk; 2) verrucous streaks; 3) re-
ticulated hyperpigmentation; and 4) finally a linear hypopig-
mented band lacking hair and sweating. Other tissues are in-
volved in IP, such as the hair, teeth, nails, eyes, and CNS. CNS 
involvement occurs in 33%-50% of the cases, presenting as de-
velopmental delay, mental retardation, ataxia, spastic paralysis, 
microcephaly, and seizures. The most common neurologic com-
plication is a seizure occurring on the second or third day of life 
confined to one side of the body.
  Although IP is well-known as an inherited disorder due to 
mutations in the NEMO gene, it is usually diagnosed just only 
with pathognomic skin lesions. This report presents a Korean 
case of a female infant with IP confirmed with NEMO gene mu-
tational analysis showing neonatal seizures and progressive ce-
rebral infarction. 
CASE DESCRIPTION
A 3,040 g term female was born in a local obstetrical clinic via a 
normal vaginal delivery after an uncomplicated pregnancy on 
May 1, 2009. Her mother was a healthy G2P1 with a healthy 22- 
month-old son. The baby was 53 cm tall (50-90 percentile) and 
had a head circumference of 34.3 cm (10-50 percentile), both of 
which were favorable. During the delivery, the baby was well, 
although erythematous vesicular eruptions were observed on 
the upper and lower extremities on the first day of life. On the 
third day of life, the baby was transferred to our hospital because 
the skin eruptions increased to cover the entire body, and con-
sisted of erythema and bullae, mostly arranged in lines. The lab-
oratory tests revealed no abnormalities in the full blood count, 
serum electrolytes, glucose, prothrombin time (PT), activated 
partial thromboplastin time (aPTT), calcium, magnesium, and 
C-reactive protein, although the eosinophil count was as high as 
44% (normal range 0%-10%). Furthermore, echocardiography, 
serologic tests for congenital infection, and metabolic screen-
ing tests remained normal. An auditory screening test was also 
normal, while a small focal hemorrhage was seen on the right 
retina. A biopsy of a vesicle on the arm showed epidermal spon-
giosis with numerous eosinophils within the epidermis (eosin-
ophilic spongiosis) and some dyskeratotic keratinocytes, con-
sistent with the vesicular stage of IP. Genomic DNA was isolated 
from the patient’s peripheral blood leukocytes. Multiplex poly-
merase chain reaction (PCR) was performed to identify the com-
mon deletion as either NEMO or ∆NEMO by using two forward 
primers (Int3s and Rep3s) and one single reverse primer (L2Rev), 
described by Steffann et al. (1). A 1,045-bp sized product was 
observed for all the samples, including the patient sample and 
positive controls, harboring deletions involving exons 4 to 10 of 
either the NEMO or ∆NEMO (Int3s and L2Rev), whereas a 733-Lee Y, et al.  •  Incontinential Pigmenti with the NEMO Mutation
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bp product was observed in all tested specimens as an internal 
amplification control (Rep3s and L2Rev) (Fig. 1A). Confirmato-
ry long-range PCR was also performed to detect the specific ge-
netic rearrangement of the NEMO, described by Bardaro et al. 
(2). A 2.6-kb product was observed for the pathological NEMO 
deletion with a forward primer (In2) and a reverse primer (JF3R) 
(Fig. 1B). 
  Five days after birth, she developed partial clonic seizures in 
the right hand and leg lasting for 2 to 3 min. The seizures were 
treated with phenobarbital and phenytoin. Diffusion weighted 
imaging (DWI) showed gyriform high-signal-intensity lesions 
in the parietal, occipital, and frontal lobes of the cerebrum sus-
pected of being bilateral non-hemorrhagic infarctions (Fig. 2A, 
B). And contrast-enhancement of cerebellar cortex suggested 
subacute stage of cerebellar infarction (Fig. 2C). The electroen-
cephalogram (EEG) showed rare spikes and sharp waves in the 
right hemisphere.
  On the 10th day of life, a seizure manifested with apnea and 
desaturation, and occasional spikes, sharp waves and high-volt-
age delta waves appeared on the EEG at that time. On follow-up 
magnetic resonance imaging (MRI), apparent diffusion coeffi-
cient (ADC) showed low-signal-intensity lesions in the corre-
sponding areas (Fig. 3A), and DWI showed more decreased sig-
nal-intensity of previous lesions and newly developed high-sig-
nal-intensity lesions in both cerebral hemispheres, especially in 
the periventricular white matter and corpus callosum (Fig. 3B).
  The seizures ceased on the 12th day of life, although the anti-
epileptic treatment was maintained with phenobarbital. Twen-
ty days after birth, a repeat EEG showed abnormal findings of 
multiple spikes and sharp waves.
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Fig. 1. PCR-based method to discriminate NEMO gene deletion. (A) Multiplex PCR 1045-bp band corresponding to DNA amplification between Int 3s and L2 Rev primers 
indicates the presence of the common rearrangement in IP patient only. (B) Confirmatory long-range PCR shows the 2.6-kb band amplified by a forward primer (In2) and a 
reverse primer (JF3R).
A C B
Fig. 2. Initial MRI. (A, B) DWI showed gyriform high-signal-intensity lesions in the parietal, occipital, and frontal lobes of the cerebrum suspected of being bilateral non-
hemorrhagic infarctions. (C) Contrast-enhancement of cerebellar cortex suggested subacute stage of cerebellar infarction.
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Fig. 3. Follow-up MRI obtained on 10th day of birth. (A) ADC showed low-signal-inten- 
sity lesions in the corresponding areas. (B) DWI showed more decreased signal-inten- 
sity of previous lesions and newly developed high-signal-intensity lesions in both cere- 
bral hemispheres, especially in the periventricular white matter and corpus callosum. Lee Y, et al.  •  Incontinential Pigmenti with the NEMO Mutation
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  After 3 months, follow-up MRI showed mild encephalomala-
cia at the sites of the previous infarction in the cortex of both ce-
rebral and cerebellar hemispheres (Fig. 4A). But, severe atrophy 
of the periventricular white matter and corpus callosum with 
dilatation of both lateral ventricles was documented (Fig. 4B).
  The patient developed left hemiparesis and her skin lesions 
became verrucous with additional hyperpigmented streaks that 
developed on the trunk and extremities.
  Presently, she is 10 months old and undergoing follow-up 
care in the pediatrics, ophthalmology, dermatology, and reha-
bilitation medicine departments.
DISCUSSION
IP is caused by a genomic rearrangement of the NEMO gene at 
Xq28 and is inherited in an X-linked dominant manner (3). So 
far, close to 40 distinct NEMO mutations have been identified 
in IP and recent review reported that about 60%-80% of IP cases 
had NEMO mutations (4). Most of the studied patients carried 
a deletion that eliminates exons 4-10 (termed NEMO ∆4-10) and 
our patient had this deletion.
  Though there are many case reports about IP diagnosed based 
on clinical findings and on histopathological analysis of biopsy 
specimens (5), there is only one report on mutation analysis in 
Korean IP patients (6). According to the recent published report 
from China, they carried out a mutation analysis on 21 clinically 
diagnosed IP patients. In 21 patients, NEMO mutations were 
detected in 14 (66.7%) patients with IP, 13 of which were the com-
mon exon 4-10 deletion, whereas the other was a novel muta-
tion (7).
  As IP is inherited in an X-linked dominant pattern and males 
(who have only one X chromosome) die in early development, 
the affected surviving males may have a 47, XXY karyotype, so-
matic mosaicism, or a mutation that produces a milder form of 
the condition (8-10). Since the patient’s sibling was a healthy 22- 
month-old male, we wanted to determine whether the patient 
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Fig. 4. Follow-up MRI obtained after 3 months. (A) Coronal T1-weighted MRI showed 
mild encephalomalacia at the sites of the previous infarction in the cortex of both 
cerebral and cerebellar hemispheres. (B) Axial T1-weight MRI showed high signal 
lesions from gliosis in periventricular white matter and very thin corpus callosum with 
dilatation of both lateral ventricles suggesting brain atrophy.
had inherited the IKBKG mutation from one of the parents or 
had a de novo mutation. However, we could not undertake the 
DNA analysis because the parents rejected genetic counseling.
  IP patients can show various CNS manifestations (ulegyria, 
acute destructive encephalopathy, hemorrhagic necrosis, brain 
edema, and encephalitis with hemorrhagic necrosis), ocular 
manifestations, orthopedic symptoms, and dental problems, in 
addition to the characteristic skin lesions (11).
  The pathogenesis of the CNS changes in IP is poorly under-
stood, but several mechanisms (vascular, developmental, in-
flammatory, destructive, and infectious processes) have been 
proposed based on imaging and histopathologic studies (12). 
One report suggested a vascular mechanism as the major mech-
anism, with inflammation as a secondary process. Hennel et al. 
(13) described magnetic resonance angiogram (MRA) changes, 
consisting of decreased branching and poor filling of the intra-
cerebral vessels, which are indicative of a microangiopathic pro-
cess; this finding supports the hypothesized vascular origin of 
the angiopathy and infarction. The retinal vascular abnormali-
ties also support the vascular pathogenic mechanism in IP and 
show macular vasculopathy and ischemia early on. The retinal 
vascular changes observed in IP include peripheral retinal vas-
cular non-perfusion, macular infarction, macular neovascular-
ization, and preretinal neovascularization (14). During the oph-
thalmologic follow-up, our patient had a small focal hemorrhage 
on the right retina. Although MRA, an important tool for assess-
ing vasculopathy in the CNS, was not performed in this case, we 
postulate that a microangiopathic process with associated hem-
orrhagic necrosis occurred, based on the MRI and ophthalmo-
logic findings.
  Three-months after birth, follow-up MRI showed mild en-
cephalomalacia in the cortex of the cerebral and cerebellar hemi-
spheres bilaterally, but severe atrophy of the periventricular 
white matter and corpus callosum with dilatation of the ventri-
cles. Lee et al. (15) evaluated seven IP patients using MRI, and 
the patients with abnormal changes showed ventricular enlarge-
ment, white matter infarcts, cerebral atrophy, hemorrhages and 
ischemia, and evidence of cerebral infarction. The severe finding 
of periventricular leukomalacia was found only in premature 
infants, suggesting global hypoxic damage to preterm infants. 
Our patient showed encephalomalacia and severe atrophy of 
the periventricular white matter and corpus callosum with dila-
tation of the ventricles, although the baby was born at term.
  This is a Korean case of a female infant with IP confirmed with 
NEMO gene mutational analysis. This case also emphasizes that 
the neurological symptoms and signs in IP patients should be 
observed because IP can be present in diverse ways ranging from 
simple skin rashes to severe brain damage, the patients with 
greater CNS lesions require careful follow-up care involving pe-
diatricians, ophthalmologists, dermatologists, and rehabilita-
tion medicine.Lee Y, et al.  •  Incontinential Pigmenti with the NEMO Mutation
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